Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Shockwave Medical Demonstrates Consistent, Results In ‘Real-World’ Study; Investigators Presented 6-Month Data From The Full Population Of The REDUCER-I Study, Alongside Interim Long-Term Follow-Up Results To 3-Years

By Benzinga Newsdesk
April 8, 4:05 PM
Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented

SWAV

Read More
2 minute read

Johnson & Johnson’s Carvykti Stands Ahead Of Bristol Myers’ Rival Blood Cancer Therapy With FDA Approval For Wider Population

By Vandana Singh
April 8, 2:19 PM
FDA approves Johnson & Johnson's Carvykti, a BCMA-targeted therapy for relapsed or refractory multiple myeloma patients, offering hope with increased manufacturing capacity and extended collaboration efforts.

JNJ